For policies, contracts, plans, and agreements issued or renewed after 12/31/2026, requires insurers, mutual benefit societies, and health maintenance organizations to provide coverage for standard fertility preservation services for persons undergoing medically necessary treatment that may cause iatrogenic infertility.
Requires health insurance policies and contracts issued on or after 1/1/2026 to provide optional coverage for the cost of hearing aids at a minimum $1,500 per hearing aid for each hearing-impaired ear every thirty-six months. Effective 7/1/2050. (SD2)
For policies, contracts, plans, and agreements issued or renewed after 12/31/2025, requires insurers, mutual benefit societies, and health maintenance organizations to provide coverage for standard fertility preservation services for persons undergoing medically necessary treatment that may cause iatrogenic infertility. Effective 12/31/2050. (SD1)
Requires all health insurers in the State, including Medicaid managed care programs, to cover the cost of continuous glucose monitors and related supplies under certain conditions. Applies to insurance policies, contracts, plans, or agreements issued or renewed in the State after 12/31/2025.
Establishes requirements for the clinical review criteria and clinical practical guidelines used to establish step therapy protocols. Provides a process for a patient to request an exception to using step therapy protocols. Establishes insurance coverage requirements relating to the use of step therapy protocols and standards to appeal an adverse step therapy exception determination.
SB 567 establishes a state income tax credit for individuals who pay for medical travel expenses not covered by insurance. Eligible residents could reduce their income tax bill by the amount spent on qualifying travel, such as trips to specialists or treatment centers. The credit applies only to costs not reimbursed through insurance coverage. This policy directly affects people facing out-of-pocket transportation costs for medical care.
SB 967 requires Medicaid and private health insurance plans to cover intravenous ketamine therapy for treating depression. The bill mandates this coverage for eligible patients and allocates state funding to support the program. It directly affects individuals seeking this specific depression treatment and insurers who must now include it in covered services. The policy change creates a new requirement for health coverage without specifying additional eligibility criteria beyond the therapy's use for depression.
Establishes restrictions on the use of artificial intelligence, algorithms, or other software tools for purposes of decision-making in health insurance utilization reviews. Requires a licensed health care provider to review all adverse actions by the health carrier.
Beginning 1/1/2027, repeals the fourteen years and under age limit for health insurance coverage requirements for the diagnosis and treatment of autism. Repeals the maximum coverage benefit limit of $25,000 for applied behavioral analysis services.
Beginning 1/1/2027, requires health insurers, mutual benefit societies, health maintenance organizations, and health plans under the State's Medicaid managed care program to provide coverage for biomarker testing.